Antidepressant Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066244
  • May 2021
  • Pharmaceuticals
  • 120 Pages
The global Antidepressant Drugs market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Antidepressant Drugs market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Antidepressant Drugs market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Antidepressant Drugs market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Alkermes Plc., Allergan Plc., Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc., H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Antidepressant Drugs market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Antidepressant Drugs market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Antidepressant Drugs market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Antidepressant Drugs market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Antidepressant Drugs Market:
The Antidepressant Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Alkermes Plc., Allergan Plc., Bristol Myers Squibb Co., Eli Lilly and Co., GlaxoSmithKline Plc., H. Lundbeck, Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd.

Antidepressant Drugs Market Segment Analysis:
by Depressive Disorder
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Product
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Serotonin-Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Serotonin Antagonist and Reuptake Inhibitors
Othersand

Geographic Coverage for Antidepressant Drugs Market:
The market research report on global Antidepressant Drugs market offers complete analysis across various regions across the world. The Antidepressant Drugs market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Antidepressant Drugs market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Antidepressant Drugs Market Value and Forecast
  • US
  • Canada
Europe Antidepressant Drugs Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Antidepressant Drugs Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Antidepressant Drugs Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Antidepressant Drugs Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Antidepressant Drugs market report:
  • The report provides key trends of the global Antidepressant Drugs market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Antidepressant Drugs industry
  • The report covers all the recent developments of the Antidepressant Drugs market and helps to provide current industry updates
  • The report covers a detailed look over the global Antidepressant Drugs Industry and provides with significant actionable insights
  • The Antidepressant Drugs market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Antidepressant Drugs market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Antidepressant Drugs market
  • Comprehensive analysis of the Antidepressant Drugs market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Antidepressant Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Antidepressant Drugs market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Antidepressant Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Antidepressant Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Antidepressant Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Alkermes Plc.
  • Allergan Plc.
  • Bristol Myers Squibb Co.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc.
  • H. Lundbeck
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Major Depressive Disorder
  • Obsessive-Compulsive Disorder
  • Generalized Anxiety Disorder
  • Panic Disorder
  • Others
  • Tricyclic Antidepressants
  • Selective Serotonin Reuptake Inhibitors
  • Serotonin-Norepinephrine Reuptake Inhibitors
  • Monoamine Oxidase Inhibitors
  • Serotonin Antagonist and Reuptake Inhibitors
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Antidepressant Drugs Market Snapshot
          2.1.1. Global Antidepressant Drugs Market By Depressive Disorder,2019
               2.1.1.1.Major Depressive Disorder
               2.1.1.2.Obsessive-Compulsive Disorder
               2.1.1.3.Generalized Anxiety Disorder
               2.1.1.4.Panic Disorder
               2.1.1.5.Others
          2.1.2. Global Antidepressant Drugs Market By Product,2019
               2.1.2.1.Tricyclic Antidepressants
               2.1.2.2.Selective Serotonin Reuptake Inhibitors
               2.1.2.3.Serotonin-Norepinephrine Reuptake Inhibitors
               2.1.2.4.Monoamine Oxidase Inhibitors
               2.1.2.5.Serotonin Antagonist and Reuptake Inhibitors
               2.1.2.6.Others
          2.1.3. Global Antidepressant Drugs Market By End-use,2019
          2.1.4. Global Antidepressant Drugs Market By Geography,2019

3. Global Antidepressant Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Antidepressant Drugs Market Size (US$), By Depressive Disorder, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Depressive Disorder, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Depressive Disorder, 2020
     4.2. Global Antidepressant Drugs Market Size (US$), By Depressive Disorder, 2018 – 2028

5. Global Antidepressant Drugs Market Size (US$), By Product, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Product, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Product, 2020
     5.2. Global Antidepressant Drugs Market Size (US$), By Product, 2018 – 2028

6. Global Antidepressant Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Antidepressant Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Antidepressant Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Antidepressant Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Antidepressant Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Antidepressant Drugs Market Size (US$), By Depressive Disorder, 2018 – 2028
          7.2.3. North America Antidepressant Drugs Market Size (US$), By Product, 2018 – 2028
          7.2.4. North America Antidepressant Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Antidepressant Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Antidepressant Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Antidepressant Drugs Market Size (US$), By Depressive Disorder, 2018 – 2028
          7.3.3. Europe Antidepressant Drugs Market Size (US$), By Product, 2018 – 2028
          7.3.4. Europe Antidepressant Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Antidepressant Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Antidepressant Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Antidepressant Drugs Market Size (US$), By Depressive Disorder, 2018 – 2028
          7.4.3. Asia Pacific Antidepressant Drugs Market Size (US$), By Product, 2018 – 2028
          7.4.4. Asia Pacific Antidepressant Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Antidepressant Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Antidepressant Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Antidepressant Drugs Market Size (US$), By Depressive Disorder, 2018 – 2028
          7.5.3. Latin America Antidepressant Drugs Market Size (US$), By Product, 2018 – 2028
          7.5.4. Latin America Antidepressant Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Antidepressant Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Antidepressant Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Antidepressant Drugs Market Size (US$), By Depressive Disorder, 2018 – 2028
          7.6.3. MEA Antidepressant Drugs Market Size (US$), By Product, 2018 – 2028
          7.6.4. MEA Antidepressant Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Antidepressant Drugs Providers
        8.4.1 Alkermes Plc.
                8.4.1.1 Business Description
                8.4.1.2 Alkermes Plc. Geographic Operations
                8.4.1.3 Alkermes Plc. Financial Information
                8.4.1.4 Alkermes Plc. Product Positions/Portfolio
                8.4.1.5 Alkermes Plc. Key Developments
        8.4.2 Allergan Plc.
                8.4.2.1 Business Description
                8.4.2.2 Allergan Plc. Geographic Operations
                8.4.2.3 Allergan Plc. Financial Information
                8.4.2.4 Allergan Plc. Product Positions/Portfolio
                8.4.2.5 Allergan Plc. Key Developments
        8.4.3 Bristol Myers Squibb Co.
                8.4.3.1 Business Description
                8.4.3.2 Bristol Myers Squibb Co. Geographic Operations
                8.4.3.3 Bristol Myers Squibb Co. Financial Information
                8.4.3.4 Bristol Myers Squibb Co. Product Positions/Portfolio
                8.4.3.5 Bristol Myers Squibb Co. Key Developments
        8.4.4 Eli Lilly and Co.
                8.4.4.1 Business Description
                8.4.4.2 Eli Lilly and Co. Geographic Operations
                8.4.4.3 Eli Lilly and Co. Financial Information
                8.4.4.4 Eli Lilly and Co. Product Positions/Portfolio
                8.4.4.5 Eli Lilly and Co. Key Developments
        8.4.5 GlaxoSmithKline Plc.
                8.4.5.1 Business Description
                8.4.5.2 GlaxoSmithKline Plc. Geographic Operations
                8.4.5.3 GlaxoSmithKline Plc. Financial Information
                8.4.5.4 GlaxoSmithKline Plc. Product Positions/Portfolio
                8.4.5.5 GlaxoSmithKline Plc. Key Developments
        8.4.6 H. Lundbeck
                8.4.6.1 Business Description
                8.4.6.2 H. Lundbeck Geographic Operations
                8.4.6.3 H. Lundbeck Financial Information
                8.4.6.4 H. Lundbeck Product Positions/Portfolio
                8.4.6.5 H. Lundbeck Key Developments
        8.4.7 Merck & Co., Inc.
                8.4.7.1 Business Description
                8.4.7.2 Merck & Co., Inc. Geographic Operations
                8.4.7.3 Merck & Co., Inc. Financial Information
                8.4.7.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.7.5 Merck & Co., Inc. Key Developments
        8.4.8 Pfizer Inc.
                8.4.8.1 Business Description
                8.4.8.2 Pfizer Inc. Geographic Operations
                8.4.8.3 Pfizer Inc. Financial Information
                8.4.8.4 Pfizer Inc. Product Positions/Portfolio
                8.4.8.5 Pfizer Inc. Key Developments
        8.4.9 Teva Pharmaceutical Industries Ltd.
                8.4.9.1 Business Description
                8.4.9.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.9.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.9.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.9.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.10 Takeda Pharmaceutical Co. Ltd.
                8.4.10.1 Business Description
                8.4.10.2 Takeda Pharmaceutical Co. Ltd. Geographic Operations
                8.4.10.3 Takeda Pharmaceutical Co. Ltd. Financial Information
                8.4.10.4 Takeda Pharmaceutical Co. Ltd. Product Positions/Portfolio
                8.4.10.5 Takeda Pharmaceutical Co. Ltd. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Antidepressant Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Antidepressant Drugs Market Revenue, By Depressive Disorder, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Antidepressant Drugs Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Antidepressant Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Antidepressant Drugs Market Revenue, By Depressive Disorder, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Antidepressant Drugs Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Antidepressant Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Antidepressant Drugs Market Revenue, By Depressive Disorder, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Antidepressant Drugs Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Antidepressant Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Antidepressant Drugs Market Revenue, By Depressive Disorder, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Antidepressant Drugs Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Antidepressant Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Antidepressant Drugs Market Revenue, By Depressive Disorder, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Antidepressant Drugs Market Revenue, By Product, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Antidepressant Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Antidepressant Drugs: Market Segmentation 
FIG. 2 Global Antidepressant Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Antidepressant Drugs Market, By Depressive Disorder, 2019 (US$ Mn) 
FIG. 5 Global Antidepressant Drugs Market, By Product, 2019 (US$ Mn) 
FIG. 6 Global Antidepressant Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Antidepressant Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Antidepressant Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Antidepressant Drugs Providers, 2019
FIG. 11 Global Antidepressant Drugs Market Revenue Contribution, By Depressive Disorder, 2019 & 2028 (Value %) 
FIG. 12 Global Antidepressant Drugs Market Revenue Contribution, By Product, 2019 & 2028 (Value %) 
FIG. 13 Global Antidepressant Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Antidepressant Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Antidepressant Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Antidepressant Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Antidepressant Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Antidepressant Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Antidepressant Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Antidepressant Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Antidepressant Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Antidepressant Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Antidepressant Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Antidepressant Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Antidepressant Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Antidepressant Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Antidepressant Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Antidepressant Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Antidepressant Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Antidepressant Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Antidepressant Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Antidepressant Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Antidepressant Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Antidepressant Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Antidepressant Drugs Market Value, By Country, 2018 – 2028
TABLE  Alkermes Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Allergan Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bristol Myers Squibb Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  H. Lundbeck: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical Co. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Antidepressant Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Antidepressant Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Antidepressant Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Antidepressant Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Antidepressant Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Antidepressant Drugs Providers, 2016
FIG.  Global Antidepressant Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Obsessive-Compulsive Disorder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Generalized Anxiety Disorder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Panic Disorder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Antidepressant Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Selective Serotonin Reuptake Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Serotonin-Norepinephrine Reuptake Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Monoamine Oxidase Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Serotonin Antagonist and Reuptake Inhibitors Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Antidepressant Drugs Market Value, 2018 – 2028, (US$ Mn)